Anonymous
Guest
Anonymous
Guest
I think we will all doing fine by the end of the year.....there has been some steady growth and if the OA indication comes through, that will definitely help all our numbers.
Good morning home office. Blah blah blah.I think we will all doing fine by the end of the year.....there has been some steady growth and if the OA indication comes through, that will definitely help all our numbers.
Ice Cream Man. You are a genius. Iroko Nation salutes you. Sell the most ice cream and water in the shortest duration of time.
2 of the reps in my area just got put on notice to get their sales up or out by end of July
I can't believe Merck, Pfizer, Lilly, and GSK didn't pay a licensing fee to utilize Solumatrix fine particle technology. Iroko is an innovator in pharma.
News flash: Analysis of zorvolex and diclofenac needed. Smart doctors see through the low dose gimmick.
They are not stupid. They are waiting for the clearance sale
The "Blue-Light Special". Will be held after third quarter if there is not exponential growth. Better be working on next position. Even if you are doing better than most. No one is making money anyway